1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow BRCA 2 Gene Mutation: new trials by email Literature Review of BRCA 2 Gene Mutation trials Research Report on BRCA 2 Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients SC10914 - Breast Cancer Metastatic, BRCA 1 Gene Mutation | Phase 2 | Unknown | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 78 | 2020-08-12 | 2020-09-21 |
| A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) talazoparib - Breast Neoplasms, BRCA 1 Gene Mutation | Phase 2 | Terminated | Pfizer | 84 | 2013-12-13 | 2019-10-14 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
talazoparib (1)
Jiangxi Qingfeng Pharmaceutical Co. Ltd. (1) · Pfizer (1)
China (1) · France (1) · Germany (1) · Spain (1) · United Kingdom (1) · United States (1)